| Literature DB >> 28750069 |
Yousang Ko1,2, Jinkyung Song1, Suh-Young Lee1,2, Jin-Wook Moon1,2, Eun-Kyung Mo1,2, Ji Young Park2,3, Joo-Hee Kim2,3, Sunghoon Park2,3, Yong Il Hwang2,3, Seung Hun Jang2,3, Byung Woo Jhun2,4, Yun Su Sim2,4, Tae Rim Shin2,4, Dong-Gyu Kim2,4, Ji Young Hong2,5, Chang Youl Lee2,5, Myung Goo Lee2,5, Cheol-Hong Kim2,6, In Gyu Hyun2,6, Yong Bum Park1,2.
Abstract
BACKGROUND: Despite recent advances in methods for culturing Mycobacterium tuberculosis (MTB), the diagnostic yield of tuberculous pleural effusion (TBPE) remains unsatisfactory. However, unlike repeated sputum cultures of pulmonary tuberculosis, little is known about the role of repeated pleural cultures. We examined whether repeated pleural cultures are associated with increased MTB yield from TBPE.Entities:
Mesh:
Year: 2017 PMID: 28750069 PMCID: PMC5531521 DOI: 10.1371/journal.pone.0181798
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart of study: Selection of study participants.
Baseline characteristics of 329 patients with TBPE.
| Single culture | Repeated culture | ||
|---|---|---|---|
| (n = 252) | (n = 77) | ||
| Age, years | 46.0 (29.3–66.8) | 49.0 (34.5–70.0) | 0.4 |
| Male gender, % | 138 (54.8) | 52 (67.5) | 0.049 |
| Time interval between first and second culture | NA | 1 (1.0–2.0) | NA |
| Comorbidity | |||
| COPD and asthma | 15 (6.0) | 4 (5.2) | 0.989 |
| Chronic liver disease | 3 (1.2) | 1 (1.3) | 0.999 |
| Diabetes | 28 (11.1) | 13 (16.9) | 0.235 |
| Cerebrovascular disease | 8 (3.2) | 6 (7.8) | 0.103 |
| Cardiovascular disease | 12 (4.8) | 6 (7.8) | 0.388 |
| Hypertension | 43(16.7) | 19 (24.7) | 0.182 |
| CKD | 6 (2.4) | 5 (6.5) | 0.138 |
| Rheumatic disease | 5 (2.0) | 4 (5.2) | 0.222 |
| Malignancy | 0 | 6 (7.8) | <0.001 |
| Radiological feature of TBPE | |||
| Loculation | 93 (36.9) | 36 (46.8) | <0.001 |
| Amount† | |||
| Large | 43 (17.1) | 12 (15.6) | 0.395 |
| Moderate | 176 (69.8)) | 59 (76.6) | |
| Small | 33 (13.1) | 6 (7.8) | |
| Effusion site | |||
| Right | 138 (54.8) | 44 (57.1) | 0.794 |
| Left | 114 (45.2) | 33 (42.9) | |
| Pleural fluid | |||
| Overall MTB culture-positive | 75 (29.8) | 34 (44.2) | <0.001 |
| only in first culture | 9 (11.7) | ||
| only in second culture | 10 (13.0) | ||
| in both first and second culture | 15 (19.5) | ||
| MTB-PCR positive | 3 (1.2) | 5 (6.5) | 0.019 |
| SG | 1.038 (1.036–1.040) | 1.038 (1.034–1.040) | 0.339 |
| WBC (total cells) | 2160.0 (1085.0–4120.0) | 1860.0 (572.5–3425.0) | 0.138 |
| Lymphocyte, % | 80.0 (64.3–90.0) | 79.0 (58.0–90.0) | 0.747 |
| Neutrophil, % | 10.0 (3.5–20.0) | 6.0 (2.0–34.0) | 0.985 |
| pH | 7.363 (7.313–7.411) | 7.368 (7.282–7.413) | 0.316 |
| Glucose (mg/dL) | 88.0 (73.0–111.5) | 85.0 (66.5–107.5) | 0.444 |
| Protein (g/dL) | 5.2 (4.7–5.6) | 5.1 (4.5–5.5) | 0.272 |
| Albumin (g/dL) | 2.9 (2.6–3.2) | 2.8 (2.4–3.1) | 0.12 |
| LDH (IU/L) | 523.5 (351.8–811.8) | 587.0 (452.8–998.5) | 0.13 |
| ADA (IU/L) | 86.7 (71.2–102.9) | 84.4 (65.9–110.6) | 0.494 |
Data are presented as the number of patients (%) or median (IQR)
TBPE, tuberculous pleural effusion; IQR, interquartile range; NA, not applicable; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; MTB, Mycobacterium tuberculosis; PCR, polymerase chain reaction; WBC, white blood cell; SG, specific gravity; LDH, lactate dehydrogenase; ADA, adenosine deaminase
*Prostate cancer (n = 1), ovary cancer (n = 1), bladder cancer (n = 1), rectal cancer (n = 1), gastric carcinoid (n = 1) and renal cell carcinoma (n = 1)
Fig 2Positive culture rate of overall and second pleural culture according to time interval between first and second culture and changes in pleural fluid characteristics.
Biochemical changes in sequential examinations of 77 cases in the repeated pleural culture group.
| First tapping | Second tapping | ||
|---|---|---|---|
| Pleural culture fluid characteristics | |||
| Positive MTB in both pleural cultures (n = 15) | |||
| WBC (total cells) | 1320.0 (291.0–3750.0) | 1730.0 (575–7720) | 0.248 |
| Lymphocyte, % | 81.0 (54.8–93.5) | 66.0 (46.3–94.0) | 0.656 |
| Neutrophil, % | 7.5 (1.8–45.8) | 19.0 (2.8–47.0) | 0.799 |
| Positive MTB only in first pleural culture (n = 9) | |||
| WBC (total cells) | 2120.0 (1775.0–4685.0) | 795.0 (272.0–1890.0) | 0.017 |
| Lymphocyte, % | 54.0 (16.5–71.0) | 79.0 (48.8–89.5) | 0.068 |
| Neutrophil, % | 35.0 (11.5–64.0) | 10.5 (4.8–31.3) | 0.063 |
| Positive MTB only in second pleural cultures (n = 10) | |||
| WBC (total cells) | 460 (183.8–2165.0) | 570.0 (277.5–2062.5) | 0.735 |
| Lymphocyte, % | 81.5 (59.3–88.5) | 80.0 (29.5–91.3) | 0.326 |
| Neutrophil, % | 5.0 (1.0–30.0) | 17.0 (5.0–47.3) | 0.036 |
| No MTB growth in both pleural culture (n = 43) | |||
| WBC (total cells) | 2130.0 (685.0–3450.0) | 1225.0 (357.5–5267.5) | 0.517 |
| Lymphocyte, % | 81.5 (60.8–92.3) | 81.0 (65.80–95.8) | 0.352 |
| Neutrophil, % | 5.5 (1.0–20.8) | 4.5 (1.3–15.0) | 0.619 |
Data are presented as median (IQR)
MTB, Mycobacterium tuberculosis; WBC, white blood cell
Comparisons of clinical, radiological, and laboratory characteristics based on MTB culture-positivity of serial pleural fluid in 77 TBPE patients.
| Positive in first culture | Positive only in second culture | No growth | ||
|---|---|---|---|---|
| (n = 24) | (n = 10) | (n = 43) | ||
| Age, years | 49.0 (34.5–68.3) | 45.5 (31.0–73.75) | 51.0 (35.0–70.0) | 0.893 |
| Male gender, % | 14 (58.3) | 8 (80.0) | 30 (69.8) | 0.42 |
| Time interval between first and second culture | 1.0 (1.0–3.0) | 1.0 (1.0–1.3) | 1.0 (1.0–2.0) | 0.34 |
| Comorbidity | ||||
| COPD and asthma | 1 (4.2) | 0 | 3 (7.0) | 0.645 |
| Chronic liver disease | 1 (4.2) | 0 | 0 | 0.327 |
| Diabetes | 2 (8.3) | 2 (20.0) | 9 (20.9) | 0.402 |
| Cerebrovascular disease | 2 (8.3) | 0 | 4 (9.3) | 0.609 |
| Cardiovascular disease | 2 (8.3) | 1 (10.0) | 3 (7.0) | 0.943 |
| Hypertension | 6 (25.0) | 4 (40.0) | 9 (20.9) | 0.452 |
| CKD | 2 (8.3) | 1 (10.0) | 2 (4.7) | 0.75 |
| Rheumatic disease | 1 (4.2) | 2 (20.0) | 1 (2.3) | 0.073 |
| Malignancy | 2 (8.3) | 1 (10.0) | 3 (7.0) | 0.943 |
| Radiological features of TBPE | ||||
| Loculation | 20 (83.3) | 8 (80.0) | 8 (18.6) | <0.001 |
| Amount | ||||
| Large | 2 (8.3) | 1 (10.0) | 9 (20.9) | 0.213 |
| Moderate | 18 (75.0) | 9 (90.0) | 32 (74.4) | |
| Small | 4 (16.7) | 0 (0.0) | 2 (4.7) | |
| Effusion site | ||||
| Right | 13 (54.2) | 6 (60.0) | 25 (58.1) | 0.934 |
| Left | 11 (45.8) | 4 (40.0) | 18 (41.9) | |
| Pleural fluid, first thoracentesis | ||||
| MTB-PCR positive | 4 (16.7) | 1 (10.0) | 0 | 0.026 |
| SG | 1.038 (1.035–1.040) | 1.040 (1.026–1.042) | 1.038 (1.034–1.040) | 0.842 |
| WBC (total cells) | 1855.0 (590.0–3732.5) | 460.0 (183.8–2165.0) | 2130.0 (685.0–3450.0) | 0.083 |
| Lymphocyte, % | 65.0 (50.0–90.0) | 81.5 (59.3–88.5) | 81.5 (60.8–92.3) | 0.354 |
| Neutrophil, % | 20.0 (3.0–58.0) | 5.0 (1.0–30.0) | 5.5 (1.0–20.8) | 0.099 |
| pH | 7.338 (7.224–7.394) | 7.266 (7.227–7.392) | 7.394 (7.301–7.428) | 0.046 |
| Glucose (mg/dL) | 78.0 (54.0–106.8) | 87.0 (46.0–134.5) | 95.0 (74.0–108.0) | 0.186 |
| Protein (g/dL) | 5.1 (4.7–5.4) | 5.5 (3.0–5.7) | 5.2 (4.5–5.4) | 0.721 |
| Albumin (g/dL) | 2.9 (2.5–3.1) | 2.8 (1.4–3.2) | 2.8 (2.3–3.1) | 0.786 |
| LDH (IU/L) | 778.5 (553.3–1185.0) | 555.0 (398.5–1265.0) | 529.0 (360.0–899.0) | 0.02 |
| ADA (IU/L) | 93.4 (72.2–106.2) | 84.3 (36.6–125.6) | 81.6 (66.3–111.4) | 0.853 |
| Pleural fluid, second thoracentesis | ||||
| WBC (total cells) | 1440.0 (467.0–3375.0) | 570.0 (277.5–2062.5) | 1225.0 (357.5–5267.5) | 0.343 |
| Lymphocyte, % | 70.5 (47.0–93.3) | 80.0 (29.5–91.3) | 81.0 (65.80–95.8) | 0.275 |
| Neutrophil, % | 17.5 (5.3–34.4) | 17.0 (5.0–47.3) | 4.5 (1.3–15.0) | 0.047 |
Data are presented as the number of patients (%) or median (IQR)
TBPE, tuberculous pleural effusion; IQR, interquartile range; NA, not applicable; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; MTB, Mycobacterium tuberculosis; PCR, polymerase chain reaction; WBC, white blood cell; SG, specific gravity; LDH, lactate dehydrogenase; ADA, adenosine deaminase
*Gout (n = 3), Sjogren syndrome (n = 1) and rheumatoid arthritis (n = 1)
†The amount of TBPE was classified as small, moderate, or large based on the following findings on chest radiographs prior to pleural tapping: (1) small, a level of TBPE that blunted the costophrenic angle but did not obscure the entire diaphragm; (2) moderate, a level that obscured the entire diaphragm but was below the hilum; (3) large, a level up to and above the hilum.
Predictors of MTB cultivation in patients with tuberculous pleural effusion via first and second pleural culture.
| Univariate analyses | Multivariate logistic regression analyses | |||
|---|---|---|---|---|
| OR (95% CI) | Adjusted OR (95% CI) | |||
| Rheumatic disease | 10.932 (0.244−489.436) | 0.218 | ||
| Loculated TBPE | 17.123 (3.501−83.745) | <0.001 | 14.061 (3.503–56.447) | <0.001 |
| Pleural fluid | ||||
| MTB-PCR positive | 13.677 (0.286−654.824) | 0.083 | ||
| Lymphocyte, % | 1.061 (0.969−1.162) | 0.203 | ||
| Neutrophil, % | 1.114 (0.991−1.251) | 0.070 | 1.031 (1.001–1.062) | 0.041 |
| pH | 0.084 (0.012−0.064) | 0.185 | ||
| Glucose (mg/dL) | 0.993 (0.967−1.020) | 0.600 | ||
| LDH (IU/L) | 1.000 (0.998−1.002) | 0.980 | ||
| Rheumatic disease | 0.251 (0.020−3.138) | 0.283 | ||
| Loculated TBPE | 6.032 (1.514−26.239) | 0.011 | 5.799 (1.488–22.549) | 0.011 |
| Pleural fluid | ||||
| Lymphocyte, % | 1.061 (0.969−1.162) | 0.202 | ||
| Neutrophil, % | 1.117 (0.993−1.257) | 0.064 | 1.039 (1.003–1.076) | 0.034 |
| Toward lymphocyte predominance | 0.866 (0.184−4.082) | 0.856 | ||
| Toward neutrophil predominance | 0.572 (0.130−2.521) | 0.308 | ||
TBPE, tuberculous pleural effusion; MTB, Mycobacterium tuberculosis; PCR, polymerase chain reaction; LDH, lactate dehydrogenase